Amlitelimab (Anti-TNFSF4 / OX40L / CD252), 1mg*5

Amlitelimab (Anti-TNFSF4 / OX40L / CD252), 1mg*5

Crenezumab (Anti-Amyloid Beta), 1mg

Crenezumab (Anti-Amyloid Beta), 1mg

Amlitelimab (Anti-TNFSF4 / OX40L / CD252), 1mg*25

19.336,31 RON
SKU
SKM_A2762_1mg*25

Amlitelimab (Anti-TNFSF4 / OX40L / CD252) is a nondepleting IgG4 human anti-OX40L monoclonal antibody with the potential to treat atopic dermatitis. MW: 145.94 kD.

Mai multe informatii
Price 16.249,00 RON (preturile sunt fara TVA)
Description

Amlitelimab (Anti-TNFSF4 / OX40L / CD252) is a nondepleting IgG4 human anti-OX40L monoclonal antibody with the potential to treat atopic dermatitis. MW: 145.94 kD.